PHOSPHOLINE IODIDE PWS 6.25MG/5ML 6.25 MG / 5 ML
ECHOTHIOPHATE IODIDE : 6.25 MG / 5 ML · DIN 02043335 · WYETH-AYERST CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is PHOSPHOLINE IODIDE PWS 6.25MG/5ML?
PHOSPHOLINE IODIDE PWS 6.25MG/5ML 6.25 MG / 5 ML contains ECHOTHIOPHATE IODIDE : 6.25 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02043335, held by WYETH-AYERST CANADA INC., supplied as POWDER FOR SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02043335 |
|---|---|
| Brand name | PHOSPHOLINE IODIDE PWS 6.25MG/5ML |
| Generic / active ingredient | ECHOTHIOPHATE IODIDE : 6.25 MG / 5 ML |
| Manufacturer | WYETH-AYERST CANADA INC. |
| Strength | 6.25 MG / 5 ML |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01EB03 ECOTHIOPATE |
| AHFS class | 52:40.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Aug-1997 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01EB03 ECOTHIOPATE. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PHOSPHOLINE IODIDE - LIQ PWS 3MG/5ML | 3 MG / 5 ML | LIQUID ; POWDER FOR SOLUTION | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02217112 |
| PHOSPHOLINE IODIDE - PWS 12.5MG/5ML | 12.5 MG / 5 ML | POWDER FOR SOLUTION | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02217139 |
| PHOSPHOLINE IODIDE - PWS 6.25MG/5ML | 6.25 MG / 5 ML | POWDER FOR SOLUTION | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02217120 |
| PHOSPHOLINE IODIDE 12.5MG/5ML | 12.5 MG / 5 ML | POWDER FOR SOLUTION | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02043343 |
| PHOSPHOLINE IODIDE 3MG/5ML | 3 MG / 5 ML | POWDER FOR SOLUTION | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02238075 |
| PHOSPHOLINE IODIDE 6.25MG/5ML | 6.25 MG / 5 ML | POWDER FOR SOLUTION | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02238076 |
| PHOSPHOLINE IODIDE PWS 3MG/5ML | 100 % / 5 ML | POWDER FOR SOLUTION ; LIQUID | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02043327 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.